Canada markets close in 19 minutes

Twist Bioscience Corporation (TWST)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
32.50+1.27 (+4.07%)
As of 03:41PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.81B
Enterprise Value 1.59B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)6.80
Price/Book (mrq)3.06
Enterprise Value/Revenue 6.05
Enterprise Value/EBITDA -9.20

Trading Information

Stock Price History

Beta (5Y Monthly) 1.62
52-Week Change 3154.73%
S&P500 52-Week Change 323.10%
52 Week High 343.21
52 Week Low 311.53
50-Day Moving Average 334.33
200-Day Moving Average 327.70

Share Statistics

Avg Vol (3 month) 3882.7k
Avg Vol (10 day) 3981.07k
Shares Outstanding 557.82M
Implied Shares Outstanding 659.3M
Float 856.95M
% Held by Insiders 11.78%
% Held by Institutions 1112.10%
Shares Short (Apr 15, 2024) 412.25M
Short Ratio (Apr 15, 2024) 417
Short % of Float (Apr 15, 2024) 427.79%
Short % of Shares Outstanding (Apr 15, 2024) 421.19%
Shares Short (prior month Mar 15, 2024) 412.01M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Sept 30, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -78.44%
Operating Margin (ttm)-65.70%

Management Effectiveness

Return on Assets (ttm)-15.87%
Return on Equity (ttm)-30.80%

Income Statement

Revenue (ttm)262.36M
Revenue Per Share (ttm)4.59
Quarterly Revenue Growth (yoy)31.80%
Gross Profit (ttm)N/A
EBITDA -176.4M
Net Income Avi to Common (ttm)-205.8M
Diluted EPS (ttm)-3.61
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)311.14M
Total Cash Per Share (mrq)5.38
Total Debt (mrq)91.88M
Total Debt/Equity (mrq)15.57%
Current Ratio (mrq)5.98
Book Value Per Share (mrq)10.21

Cash Flow Statement

Operating Cash Flow (ttm)-111.38M
Levered Free Cash Flow (ttm)-67.14M